HomeClinical TopicsFDA approves new melanoma drug

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF V600E mutation. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content